SI1224177T1 - Process for preparing oxazolines from tetrahydrofurans - Google Patents

Process for preparing oxazolines from tetrahydrofurans

Info

Publication number
SI1224177T1
SI1224177T1 SI200030333T SI200030333T SI1224177T1 SI 1224177 T1 SI1224177 T1 SI 1224177T1 SI 200030333 T SI200030333 T SI 200030333T SI 200030333 T SI200030333 T SI 200030333T SI 1224177 T1 SI1224177 T1 SI 1224177T1
Authority
SI
Slovenia
Prior art keywords
preparation
tetrahydrofurans
oxazolines
disclosed
nelfinavir
Prior art date
Application number
SI200030333T
Other languages
English (en)
Slovenian (sl)
Inventor
Juliette Kharsa Busse
Scott Edward Zook
Bennett Chaplin Borer
Original Assignee
Agouron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals, Inc. filed Critical Agouron Pharmaceuticals, Inc.
Publication of SI1224177T1 publication Critical patent/SI1224177T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SI200030333T 1999-10-21 2000-10-19 Process for preparing oxazolines from tetrahydrofurans SI1224177T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16069599P 1999-10-21 1999-10-21
EP00970988A EP1224177B1 (en) 1999-10-21 2000-10-19 Process for preparing oxazolines from tetrahydrofurans
PCT/US2000/028815 WO2001029013A1 (en) 1999-10-21 2000-10-19 Process for preparing oxazolines from tetrahydrofurans

Publications (1)

Publication Number Publication Date
SI1224177T1 true SI1224177T1 (en) 2004-06-30

Family

ID=22578030

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030333T SI1224177T1 (en) 1999-10-21 2000-10-19 Process for preparing oxazolines from tetrahydrofurans

Country Status (21)

Country Link
US (3) US6403799B1 (xx)
EP (1) EP1224177B1 (xx)
JP (2) JP2003512361A (xx)
KR (1) KR100706938B1 (xx)
CN (3) CN1539834A (xx)
AT (1) ATE259360T1 (xx)
AU (1) AU775783B2 (xx)
BR (1) BR0015229A (xx)
CA (1) CA2387997C (xx)
CZ (1) CZ20021361A3 (xx)
DE (1) DE60008270T2 (xx)
DK (1) DK1224177T3 (xx)
ES (1) ES2215737T3 (xx)
HK (2) HK1051365A1 (xx)
HU (1) HUP0203214A3 (xx)
IL (1) IL149197A0 (xx)
PL (1) PL364878A1 (xx)
PT (1) PT1224177E (xx)
RU (1) RU2242468C2 (xx)
SI (1) SI1224177T1 (xx)
WO (1) WO2001029013A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201500125QA (en) 2012-07-11 2015-02-27 Blueprint Medicines Corp Inhibitors of the fibroblast growth factor receptor
WO2015061572A1 (en) 2013-10-25 2015-04-30 Blueprint Medicines Corporation Inhibitors of the fibroblast growth factor receptor
US9695165B2 (en) 2014-01-15 2017-07-04 Blueprint Medicines Corporation Inhibitors of the fibroblast growth factor receptor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
WO1994015906A1 (en) 1993-01-15 1994-07-21 Agouron Pharmaceuticals, Inc. Hiv protease inhibitors and their preparation
EP0686157A1 (en) 1993-02-26 1995-12-13 Schering Corporation 2-benzyl-polycyclic guanine derivatives and process for preparing them
US5527829A (en) 1994-05-23 1996-06-18 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
EP0983999B8 (en) 1995-09-26 2005-06-08 Japan Tobacco Inc. Process for producing amide derivatives and intermediates
US6121468A (en) 1995-09-26 2000-09-19 Japan Tobacco Inc. Process for producing amide derivatives and intermediate compounds
US5925759A (en) * 1996-09-05 1999-07-20 Agouron Pharmaceuticals, Inc. Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
US5962725A (en) * 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US6001851A (en) * 1997-03-13 1999-12-14 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
RU2242468C2 (ru) 2004-12-20
IL149197A0 (en) 2002-11-10
US20030023092A1 (en) 2003-01-30
AU775783B2 (en) 2004-08-12
JP2008007522A (ja) 2008-01-17
HK1051365A1 (en) 2003-08-01
US6472534B2 (en) 2002-10-29
KR100706938B1 (ko) 2007-04-11
DE60008270T2 (de) 2004-07-15
DK1224177T3 (da) 2004-05-03
US6403799B1 (en) 2002-06-11
CN1390210A (zh) 2003-01-08
KR20020047255A (ko) 2002-06-21
BR0015229A (pt) 2002-07-23
PL364878A1 (en) 2004-12-27
US20020038033A1 (en) 2002-03-28
AU8029000A (en) 2001-04-30
HUP0203214A3 (en) 2005-01-28
EP1224177B1 (en) 2004-02-11
JP2003512361A (ja) 2003-04-02
HK1068880A1 (en) 2005-05-06
EP1224177A1 (en) 2002-07-24
CA2387997C (en) 2006-06-13
CA2387997A1 (en) 2001-04-26
CN1539832A (zh) 2004-10-27
CN1162408C (zh) 2004-08-18
DE60008270D1 (de) 2004-03-18
CN1539834A (zh) 2004-10-27
CN1266140C (zh) 2006-07-26
CZ20021361A3 (cs) 2003-03-12
HUP0203214A2 (hu) 2003-01-28
PT1224177E (pt) 2004-06-30
WO2001029013A1 (en) 2001-04-26
ES2215737T3 (es) 2004-10-16
ATE259360T1 (de) 2004-02-15

Similar Documents

Publication Publication Date Title
DK0835257T3 (da) Mellemprodukter og fremgangsmåde til fremstilling af camptothecin-derivater (CPT-11) og beslægtede forbindelser
CA2405486A1 (fr) Procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
IL149846A0 (en) Method for obtaining nucleic acids from an evironment sample, resulting nucleic acids and use in synthesis of novel compounds
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
HK1068880A1 (en) Process for preparing oxazolines from tetrahydroforans
AP2002002641A0 (en) Estrogen agonist metabolites.
IL195385A0 (en) A process for preparing arylamine derivatives
YU30202A (sh) Postupak za dobijanje oksazolina iz tetrahidrofurana
WO2004026814A3 (en) Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
BG104243A (en) Method for the synthesis of quinoline derivatives
DK1089976T3 (da) Fremgangsmåde til fremstilling af 5-bromisoquinolin og dets 8-nitroderivat
NO20024503D0 (no) Fremgangsmåte for tilföring av startkulturer med en reproduserbar kvalitet
DE69903291T2 (de) Synthese von morphin-6-glucuronid
RS20050760A (sr) Postupak za izradu fenilamida 5-(4- fluorofenil)-1-(2-((2r, 4r)-4-hidroksi- 6-okso-tetrahidro-piran-2-il)etil)-2- izopropil-4-fenil-1h-pirol-3- karboksilne kiseline
HRP20020021B1 (en) Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates
RU2003132433A (ru) Способ получения 2-[5-(4-фторфенил)-3- пиридилметиламинометил]хромана
IL156078A0 (en) Cyclizing method for synthesis of compounds derived from pyrrolidine
NO20055836L (no) Intermediater anvendelige ved syntesen av HIV-proteaseinhibitorer og fremgangsmater for fremstilling av samme
YU23301A (sh) Postupak za dobijanje supstituisanih piridina
DK1331218T3 (da) Fremgangsmåde til fremstilling af beskyttet 3-amino-1,2-dihydroxypropanacetal og derivater deraf
DK1268441T3 (da) Mellemprodukt og fremgangsmåde til dets syntese
AU2000246281A1 (en) Piperidine compounds and process for providing such
HUP9800542A2 (hu) Epoxi-azetidinonok, eljárás előállításukra és alkalmazásuk
NO20010122L (no) Fremgangsmåte for stereoselektiv fremstilling av Grignard- forbindelser og anvendelse derav